Abstract:Background: Emerging evidence indicates that reactive microglia-initiated inflammatory responses are responsible for secondary damage after primary traumatic spinal cord injury (SCI); epidermal growth factor receptor (EGFR) signaling may be involved in cell activation. In this report, we investigate the influence of EGFR signaling inhibition on microglia activation, proinflammatory cytokine production, and the neuronal microenvironment after SCI. Methods: Lipopolysaccharide-treated primary microglia/BV2 line cells and SCI rats were used as model systems. Both C225 and AG1478 were used to inhibit EGFR signaling activation. Cell activation and EGFR phosphorylation were observed after fluorescent staining and western blot. Production of interleukin-1 beta (IL-1 β) and tumor necrosis factor alpha (TNF α) was tested by reverse transcription PCR and ELISA. Western blot was performed to semi-quantify the expression of EGFR/phospho-EGFR, and phosphorylation of Erk, JNK and p38 mitogen-activated protein kinases (MAPK). Wet-dry weight was compared to show tissue edema. Finally, axonal tracing and functional scoring were performed to show recovery of rats. Results: EGFR phosphorylation was found to parallel microglia activation, while EGFR blockade inhibited activation-associated cell morphological changes and production of IL-1 β and TNF α. EGFR blockade significantly downregulated the elevated MAPK activation after cell activation; selective MAPK inhibitors depressed production of cytokines to a certain degree, suggesting that MAPK mediates the depression of microglia activation brought about by EGFR inhibitors. Subsequently, seven-day continual infusion of C225 or AG1478 in rats: reduced the expression of phospho-EGFR, phosphorylation of Erk and p38 MAPK, and production of IL-1 β and TNF α; lessened neuroinflammation-associated secondary damage, like microglia/astrocyte activation, tissue edema and glial scar/cavity formation; and enhanced axonal outgrowth and functional recovery. Conclusions: These findings indicate that inhibition of EGFR/MAPK suppresses microglia activation and associated cytokine production; reduces neuroinflammation-associated secondary damage, thus provides neuroprotection to SCI rats, suggesting that EGFR may be a therapeutic target, and C225 and AG1478 have potential for use in SCI treatment.

Epidermal Growth Factor Receptor Activation: an Upstream Signal for Transition of Quiescent Astrocytes into Reactive Astrocytes after Neural Injury

Activation of epidermal growth factor receptors in astrocytes: from development to neural injury.

Signaling Pathways Regulating Neuron–glia Interaction and Their Implications in Alzheimer's Disease

Activation of epidermal growth factor receptor causes astrocytes to form cribriform structures.

Insight into Astrocyte Activation after Optic Nerve Injury

CTGF Triggers Rat Astrocyte Activation and Astrocyte-Mediated Inflammatory Response in Culture Conditions

Blocking Epidermal Growth Factor Receptor Attenuates Reactive Astrogliosis Through Inhibiting Cell Cycle Progression and Protects Against Ischemic Brain Injury in Rats.

Activation of Epidermal Growth Factor Receptor Signals Induction of Nitric Oxide Synthase-2 in Human Optic Nerve Head Astrocytes in Glaucomatous Optic Neuropathy.

Activation of Epidermal Growth Factor Receptors Directs Astrocytes to Organize in a Network Surrounding Axons in the Developing Rat Optic Nerve.

Signal transduction pathways for epidermal growth factor stimulated cyclooxygenase-2 induction in astrocytes

A role for ErbB signaling in the induction of reactive astrogliosis

A molecular switch for neuroprotective astrocyte reactivity

Different epidermal growth factor receptor signaling pathways in neurons and astrocytes activated by extracellular matrix after spinal cord injury

Optic nerve astrocyte reactivity protects function in experimental glaucoma and other nerve injuries

Chronic activation of astrocytic G GPCR signaling has causal effects on visual LTP formation: implications for neurodegenerative diseases

Expression and Activation of STAT3 in the Astrocytes of Optic Nerve in a Rat Model of Transient Intraocular Hypertension.

Epidermal Growth Factor Receptor Signaling Pathway Activation Mediating Inflammatory Damage in Central Nervous System

Reciprocal Modulation Between Microglia and Astrocyte in Reactive Gliosis Following the CNS Injury

Glaucornatous Optic Neuropathy: when Glia Misbehave

Optogenetic Manipulation of Astrocytes from Synapses to Neuronal Networks: A Potential Therapeutic Strategy for Neurodegenerative Diseases

Inhibition of EGFR/MAPK signaling reduces microglial inflammatory response and the associated secondary damage in rats after spinal cord injury